NCT01733238View on ClinicalTrials.gov

Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Lymphoma, Non-Hodgkin's
Interventions
DRUG

PNT2258

Trial Locations (3)

47905

Horizon Oncology Research, Inc., Lafayette

48236

St. John Hospital and Medical Center, Van Elslander Cancer Center, Grosse Pointe Woods

49503

Cancer and Hematology Centers of Western Michigan, P.C., Grand Rapids

All Listed Sponsors
lead

Sierra Oncology LLC - a GSK company

INDUSTRY

NCT01733238 - Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter